Remove 2012 Remove End-of-life care Remove Hospice Remove Patient care
article thumbnail

New Directors at Iowa River, Home Health of the Ozarks; C-Suite Shifts at Elara Caring, VIA Health

Hospice News

Home Health of the Ozarks and Hospice of Care Names New Director Missouri-based Texas County Memorial Hospital (TCMH) has appointed Cheryl Maley, registered nurse, as new director of Home Health of the Ozarks and Hospice of Care. The nonprofit hospice is supported by TCMH Healthcare Foundation’s Hospice Memorial Fund.

article thumbnail

Blue Monarch CEO: Hospice Startup Seeks to Raise Bar on Quality

Hospice News

Nurse practitioner Raphael and registered nurse Britt Akobundu, a married couple, launched San Diego-based Blue Monarch Hospice this past March, with the intent of improving the quality of life for not only patients and families, but also health care workers. .

Hospice 264
professionals

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Compassus Makes Moves in C-Suite; Workforce Retention at Core of AccentCare’s Leadership Change

Hospice News

Since joining the company in 2012, Templeton has served as senior vice president and chief of clinical operations. The Tennessee-based company offers community-based hospice, infusion therapy, home health, and palliative care across 200 locations in 30 states. New COO Takes Helm at Compassus. David Cook, Jr.

Palliate 234
article thumbnail

Why Patients with Lymphoma Are Less Likely to Receive Hospice

1-800-HOSPICE

The American Society of Clinical Oncology describes hospice as an essential component of end-of-life (EOL) care. 1 As such, hospice utilization among patients with hematologic malignancies merits scrutiny as an area where hospice utilization is traditionally lower than with solid malignancies.

article thumbnail

Roger Chou’s Undisclosed Conflicts of Interest: How the CDC’s 2016 Guideline for Prescribing Opioids for Chronic Pain Lost Its Clinical and Professional Integrity

Pallimed

Chou had originally announced his intention to help influence opioid policy in a 2011 article that he co-authored with PROP’s founders (5), and he was a bold signatory to PROP’s 2012 Petition to the Food and Drug Administration (FDA) to change opioid labeling (6; See Figures 1a and 1b: First page and signatory page.)

2016 89